Amylyx features the drug that slows down the progression of the disease

2023-06-23 16:33:02

On World Amyotrophic Lateral Sclerosis (ALS) Day, Amylyx presented AMX0035, “the first drug capable of slowing the progression of the disease”, as stated by Justin Klee – Co-Founder and Co-CEO of Amylyx Pharmaceuticals and Giovanni Galliano – General Manager of Amylyx Italy.